Chronic Inflammation
-
Study details early events of inflammatory response
Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis. Read MoreDec 10, 2020
-
Risk marker for repeat sinus surgery
An inflammatory factor in mucus could be a biomarker of treatment-resistant chronic sinusitis used to determine which patients are at risk for repeat sinus surgery. Read MoreAug 11, 2020
-
New treatment for Crohn’s disease
A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease. Read MoreMar 22, 2016
-
Lymphocyte study reveals obesity clues
Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes. Read MoreOct 16, 2014